{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:09:11Z","timestamp":1792807751726,"version":"4.5.0"},"reference-count":56,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The role of different adjunctive tirofiban administration routes during endovascular thrombectomy (EVT) for acute ischemic stroke (AIS) due to large artery atherosclerosis (LAA) remains controversial. We evaluated the efficacy and safety of intravenous (IV) alone and combined intra-arterial and intravenous (IA\u00a0+\u00a0IV) tirofiban in patients with LAA-related AIS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      This individual patient data pooled analysis included 850 anterior circulation large vessel occlusion (LVO) patients due to LAA from two Chinese randomized trials (RESCUE BT and MARVEL). Patients were categorized into three groups: EVT alone (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a0360), Tirofiban-IV (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a0385), and Tirofiban-(IA\u00a0+\u00a0IV) (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a0105). The primary outcome was 90-day functional independence [modified Rankin Scale (mRS) 0\u20132]. Safety outcomes included symptomatic intracranial hemorrhage (sICH) within 48\u00a0hours, any ICH, and 90-day mortality. Inverse probability of treatment weighting (IPTW) and propensity score matching (PSM) were used for baseline adjustment.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Among 850 eligible patients included in this analysis, the median age was 66\u00a0years, and 70.9% (\n                      <jats:italic toggle=\"yes\">n<\/jats:italic>\n                      =\u00a0603) were male. Both tirofiban regimens were associated with improved functional independence compared to EVT alone: Tirofiban-IV group [51.9 vs. 37.2%; adjusted odds ratio (aOR)\u00a0=\u00a01.90, 95% CI 1.39\u20132.59;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01] and Tirofiban-(IA\u00a0+\u00a0IV) group (46.7 vs. 37.2%; aOR\u00a0=\u00a01.97, 95%CI 1.22\u20133.17;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01). Notably, both tirofiban strategies enhanced successful recanalization rates [expanded thrombolysis in cerebral infarction (eTICI) \u2265 2b]. The Tirofiban-IV group achieved 92.5% versus 83.3% in the EVT-alone group (aOR\u00a0=\u00a02.43, 95% CI 1.51\u20133.92;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.01), with comparable efficacy in the Tirofiban-(IA\u00a0+\u00a0IV) group (91.4 vs. 83.3%; aOR\u00a0=\u00a02.47, 95%CI 1.15\u20135.30;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.02). Moreover, neither the Tirofiban-IV group (sICH: aOR\u00a0=\u00a00.75, 95% CI 0.44\u20131.27,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.29; mortality: aOR\u00a0=\u00a00.77, 95% CI 0.52\u20131.14,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.20) nor the Tirofiban-(IA\u00a0+\u00a0IV) group (sICH: aOR\u00a0=\u00a00.49, 95% CI 0.20\u20131.23,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.13; mortality: aOR\u00a0=\u00a00.64, 95% CI 0.35\u20131.18,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.15) showed increased risks of sICH or mortality compared to the EVT-alone group. These results remained robust in PSM sensitivity analyses.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>In patients with anterior circulation LVO secondary to LAA undergoing EVT, adjunctive tirofiban, whether administered IV or via a combined IA\u00a0+\u00a0IV approach, was associated with superior 90-day functional outcomes and enhanced recanalization efficacy, without an increased risk of sICH or mortality.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000004601","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T13:00:15Z","timestamp":1766408415000},"page":"9857-9866","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Efficacy and safety of adjunctive tirofiban administration in anterior large vessel occlusion due to large artery atherosclerosis: an individual patient data pooled analysis of two randomized clinical trials"],"prefix":"10.1097","volume":"112","author":[{"given":"Renjie","family":"Ji","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shitao","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengsong","family":"Yue","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changwei","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfang","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxing","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Nursing, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahong","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihai","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linyu","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixian","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhe","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenxuan","family":"Tian","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfu","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojian","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizhen","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benyan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5899-9270","authenticated-orcid":false,"given":"Fengli","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Xinqiao Hospital and The Second Affiliated Hospital, Army Medical University (Third Military Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"R1-20260424","doi-asserted-by":"crossref","first-page":"1723\u201331","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"Goyal","year":"2016","journal-title":"Lancet"},{"key":"R2-20260424","doi-asserted-by":"crossref","first-page":"14\u201318","DOI":"10.1136\/neurintsurg-2020-015889","article-title":"Predictors of poor clinical outcome despite complete reperfusion in acute ischemic stroke patients","volume":"13","author":"van Horn","year":"2021","journal-title":"J Neurointerv Surg"},{"key":"R3-20260424","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/s13063-020-04514-9","article-title":"Multicenter randomized clinical trial of endovascular treatment for acute ischemic stroke. the effect of periprocedural medication: acetylsalicylic acid, unfractionated heparin, both, or neither (MR CLEAN-MED). rationale and study design","volume":"21","author":"Chalos","year":"2020","journal-title":"Trials"},{"key":"R4-20260424","doi-asserted-by":"crossref","first-page":"965\u201374","DOI":"10.1016\/S0140-6736(23)01142-X","article-title":"Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials","volume":"402","author":"Majoie","year":"2023","journal-title":"Lancet"},{"key":"R5-20260424","doi-asserted-by":"crossref","first-page":"826\u201335","DOI":"10.1001\/jama.2022.1645","article-title":"Effect of intra-arterial alteplase vs placebo following successful thrombectomy on functional outcomes in patients with large vessel occlusion acute ischemic stroke: the CHOICE randomized clinical trial","volume":"327","author":"Renu","year":"2022","journal-title":"JAMA"},{"key":"R6-20260424","doi-asserted-by":"crossref","first-page":"589\u201398","DOI":"10.1001\/jama.2024.23480","article-title":"Intra-arterial urokinase after endovascular reperfusion for acute ischemic stroke: the POST-UK randomized clinical trial","volume":"333","author":"Liu","year":"2025","journal-title":"JAMA"},{"key":"R7-20260424","doi-asserted-by":"crossref","first-page":"579\u201388","DOI":"10.1001\/jama.2024.23466","article-title":"Intra-arterial tenecteplase following endovascular reperfusion for large vessel occlusion acute ischemic stroke: the POST-TNK randomized clinical trial","volume":"333","author":"Huang","year":"2025","journal-title":"JAMA"},{"key":"R8-20260424","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jama.2025.10800","article-title":"Intra-arterial tenecteplase for acute stroke after successful endovascular therapy: the ANGEL-TNK randomized clinical trial","volume":"334","author":"Miao","year":"2025","journal-title":"JAMA"},{"key":"R9-20260424","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1212\/WNL.0000000000012781","article-title":"Global epidemiology of stroke and access to acute ischemic stroke interventions","volume":"97","author":"Saini","year":"2021","journal-title":"Neurology"},{"key":"R10-20260424","first-page":"1949\u201356","article-title":"Endovascular treatment for emergent large vessel occlusion due to severe intracranial atherosclerotic stenosis","volume":"130","author":"Kang","year":"2019","journal-title":"J Neurosurg"},{"key":"R11-20260424","doi-asserted-by":"crossref","first-page":"2699\u2013705","DOI":"10.1161\/STROKEAHA.118.022327","article-title":"Outcomes of Endovascular Treatment for Acute Intracranial Atherosclerosis-Related Large Vessel Occlusion","volume":"49","author":"Baek","year":"2018","journal-title":"Stroke"},{"key":"R12-20260424","doi-asserted-by":"crossref","first-page":"1099\u2013106","DOI":"10.1161\/STROKEAHA.114.007494","article-title":"Endothelial trauma from mechanical thrombectomy in acute stroke: in vitro live-cell platform with animal validation","volume":"46","author":"Teng","year":"2015","journal-title":"Stroke"},{"key":"R13-20260424","doi-asserted-by":"crossref","first-page":"1684\u201387","DOI":"10.1212\/01.WNL.0000063323.23493.98","article-title":"Immediate reocclusion following a successful thrombolysis in acute stroke: a pilot study","volume":"60","author":"Heo","year":"2003","journal-title":"Neurology"},{"key":"R14-20260424","doi-asserted-by":"crossref","first-page":"948\u201351","DOI":"10.1136\/neurintsurg-2016-012529","article-title":"Endovascular treatment for AIS with underlying ICAD","volume":"9","author":"Al Kasab","year":"2017","journal-title":"J Neurointerv Surg"},{"key":"R15-20260424","doi-asserted-by":"crossref","first-page":"351\u201370","DOI":"10.1185\/03007995.2012.657299","article-title":"Treatment with tirofiban for acute coronary syndrome (ACS): a systematic review and network analysis","volume":"28","author":"Lang","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"R16-20260424","doi-asserted-by":"crossref","first-page":"35\u201349","DOI":"10.1093\/eurheartj\/ehp376","article-title":"Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials","volume":"31","author":"Valgimigli","year":"2010","journal-title":"Eur Heart J"},{"key":"R17-20260424","doi-asserted-by":"crossref","first-page":"3289\u201394","DOI":"10.1161\/STROKEAHA.117.019193","article-title":"Low-dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy","volume":"48","author":"Zhao","year":"2017","journal-title":"Stroke"},{"key":"R18-20260424","doi-asserted-by":"crossref","first-page":"1105\u201310","DOI":"10.1111\/ene.13946","article-title":"Safety and efficacy of tirofiban combined with endovascular treatment in acute ischaemic stroke","volume":"26","author":"Pan","year":"2019","journal-title":"Eur J Neurol"},{"key":"R19-20260424","doi-asserted-by":"crossref","first-page":"1336098","DOI":"10.3389\/fneur.2024.1336098","article-title":"The impact of intraarterial, intravenous, and combined tirofiban on endovascular treatment for acute intracranial atherosclerotic occlusion","volume":"15","author":"Bu","year":"2024","journal-title":"Front Neurol"},{"key":"R20-20260424","first-page":"1453\u201355","article-title":"Endovascular stroke therapy: tirofiban is associated with risk of fatal intracerebral hemorrhage and poor outcome","volume":"44","author":"Kellert","year":"2013","journal-title":"Stroke"},{"key":"R21-20260424","doi-asserted-by":"crossref","first-page":"107303\u201311","DOI":"10.18632\/oncotarget.19179","article-title":"Intracoronary administration of tirofiban during percutaneous coronary intervention facilitates patients with acute coronary syndrome","volume":"8","author":"Jia","year":"2017","journal-title":"Oncotarget"},{"key":"R22-20260424","first-page":"100082","article-title":"Transparency in the reporting of Artificial Intelligence -The TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R23-20260424","first-page":"543\u201353","article-title":"Effect of intravenous tirofiban vs placebo before endovascular thrombectomy on functional outcomes in large vessel occlusion stroke: the RESCUE BT randomized clinical trial","volume":"328","author":"Qiu","year":"2022","journal-title":"JAMA"},{"key":"R24-20260424","first-page":"840\u201349","article-title":"Methylprednisolone as adjunct to endovascular thrombectomy for large-vessel occlusion stroke: the MARVEL randomized clinical trial","volume":"331","author":"Yang","year":"2024","journal-title":"JAMA"},{"key":"R25-20260424","doi-asserted-by":"crossref","first-page":"e081123","DOI":"10.1136\/bmj-2024-081123","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"389","author":"Hopewell","year":"2025","journal-title":"Bmj"},{"key":"R26-20260424","doi-asserted-by":"crossref","first-page":"35\u201341","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. definitions for use in a multicenter clinical trial. TOAST. trial of org 10172 in acute stroke treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"R27-20260424","doi-asserted-by":"crossref","first-page":"604\u201307","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"R28-20260424","doi-asserted-by":"crossref","first-page":"433\u201338","DOI":"10.1136\/neurintsurg-2018-014127","article-title":"eTICI reperfusion: defining success in endovascular stroke therapy","volume":"11","author":"Liebeskind","year":"2019","journal-title":"J Neurointerv Surg"},{"key":"R29-20260424","doi-asserted-by":"crossref","first-page":"2981\u201386","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The heidelberg bleeding classification: classification of bleeding events after ischemic stroke and reperfusion therapy","volume":"46","author":"von Kummer","year":"2015","journal-title":"Stroke"},{"key":"R30-20260424","doi-asserted-by":"crossref","first-page":"1172\u201377","DOI":"10.1161\/STROKEAHA.119.024928","article-title":"Rapid neurologic improvement predicts favorable outcome 90 days after thrombectomy in the DEFUSE 3 study","volume":"50","author":"Heit","year":"2019","journal-title":"Stroke"},{"key":"R31-20260424","doi-asserted-by":"crossref","first-page":"117\u201323","DOI":"10.1111\/ene.14487","article-title":"Neurological improvement predicts clinical outcome after acute basilar artery stroke thrombectomy","volume":"28","author":"Guenego","year":"2021","journal-title":"Eur J Neurol"},{"key":"R32-20260424","doi-asserted-by":"crossref","first-page":"404\u201310","DOI":"10.1177\/15910199211038207","article-title":"Delayed neurological improvement is predictive to long-term clinical outcome on endovascular thrombectomy patients","volume":"28","author":"Cai","year":"2022","journal-title":"Interv Neuroradiol"},{"key":"R33-20260424","doi-asserted-by":"crossref","first-page":"2925\u201333","DOI":"10.1161\/STROKEAHA.120.029994","article-title":"Intraarterial versus intravenous tirofiban as an adjunct to endovascular thrombectomy for acute ischemic stroke","volume":"51","author":"Yang","year":"2020","journal-title":"Stroke"},{"key":"R34-20260424","doi-asserted-by":"crossref","first-page":"630301","DOI":"10.3389\/fneur.2021.630301","article-title":"Safety and efficacy of tirofiban for acute ischemic stroke patients with large artery atherosclerosis stroke etiology undergoing endovascular therapy","volume":"12","author":"Huo","year":"2021","journal-title":"Front Neurol"},{"key":"R35-20260424","doi-asserted-by":"crossref","first-page":"1690\u201395","DOI":"10.3174\/ajnr.A4770","article-title":"Incidence and clinical significance of acute reocclusion after emergent angioplasty or stenting for underlying intracranial stenosis in patients with acute stroke","volume":"37","author":"Kim","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"R36-20260424","doi-asserted-by":"crossref","first-page":"743\u201349","DOI":"10.1136\/neurintsurg-2016-012533","article-title":"A comparison of acute vascular damage caused by ADAPT versus a stent retriever device after thrombectomy in acute ischemic stroke: a histological and ultrastructural study in an animal model","volume":"9","author":"Peschillo","year":"2017","journal-title":"J Neurointerv Surg"},{"key":"R37-20260424","doi-asserted-by":"crossref","first-page":"712\u201319","DOI":"10.1177\/17474930221148894","article-title":"Early reocclusion after successful mechanical thrombectomy for large artery occlusion-related stroke","volume":"18","author":"Dhoisne","year":"2023","journal-title":"Int J Stroke"},{"key":"R38-20260424","doi-asserted-by":"crossref","first-page":"350\u201355","DOI":"10.1159\/000362435","article-title":"Instant reocclusion following mechanical thrombectomy of in situ thromboocclusion and the role of low-dose intra-arterial tirofiban","volume":"37","author":"Kang","year":"2014","journal-title":"Cerebrovasc Dis"},{"key":"R39-20260424","first-page":"515\u201329","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibitor tirofiban in acute ischemic stroke","volume":"79","author":"Yang","year":"2019","journal-title":"Drugs"},{"key":"R40-20260424","doi-asserted-by":"crossref","first-page":"96\u2013101","DOI":"10.5853\/jos.2015.01347","article-title":"Primary stent retrieval for acute intracranial large artery occlusion due to atherosclerotic disease","volume":"18","author":"Lee","year":"2016","journal-title":"J Stroke"},{"key":"R41-20260424","doi-asserted-by":"crossref","first-page":"339\u201347","DOI":"10.1097\/00001721-200206000-00010","article-title":"Sequential alterations in haemorheology, endothelial dysfunction, platelet activation and thrombogenesis in relation to prognosis following acute stroke: the west birmingham stroke project","volume":"13","author":"Lip","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R42-20260424","doi-asserted-by":"crossref","first-page":"1075\u201379","DOI":"10.1001\/archneur.1990.00530100037011","article-title":"Altered coagulation in cerebral ischemia. platelet, thrombin, and plasmin activity","volume":"47","author":"Fisher","year":"1990","journal-title":"Arch Neurol"},{"key":"R43-20260424","doi-asserted-by":"crossref","first-page":"1519\u201323","DOI":"10.1161\/01.ATV.0000167524.69092.16","article-title":"Platelet-leukocyte interaction and platelet activation in acute stroke with and without preceding infection","volume":"25","author":"Zeller","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R44-20260424","doi-asserted-by":"crossref","first-page":"1798\u2013804","DOI":"10.1161\/01.STR.0000226897.43749.27","article-title":"Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke","volume":"37","author":"Tanne","year":"2006","journal-title":"Stroke"},{"key":"R45-20260424","doi-asserted-by":"crossref","first-page":"1066\u201373","DOI":"10.1016\/S0021-9258(18)54042-4","article-title":"Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa","volume":"268","author":"Scarborough","year":"1993","journal-title":"J Biol Chem"},{"key":"R46-20260424","doi-asserted-by":"crossref","first-page":"1301\u201310","DOI":"10.1172\/JCI3338","article-title":"Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting GP IIb\/IIIa receptor-mediated platelet aggregation","volume":"102","author":"Choudhri","year":"1998","journal-title":"J Clin Invest"},{"key":"R47-20260424","doi-asserted-by":"crossref","first-page":"2837\u201343","DOI":"10.1161\/01.CIR.0000068374.57764.EB","article-title":"Adjuvant treatment with a glycoprotein IIb\/IIIa receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke","volume":"107","author":"Zhang","year":"2003","journal-title":"Circulation"},{"key":"R48-20260424","doi-asserted-by":"crossref","first-page":"1217\u201325","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.11.042","article-title":"Combination of 24-hour and 7-day relative neurological improvement strongly predicts 90-day functional outcome of endovascular stroke therapy","volume":"27","author":"Pu","year":"2018","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"R49-20260424","doi-asserted-by":"crossref","first-page":"547\u201351","DOI":"10.1136\/neurintsurg-2022-019008","article-title":"Early neurological improvement as a predictor of outcomes after endovascular thrombectomy for stroke: a systematic review and meta-analysis","volume":"15","author":"Kobeissi","year":"2023","journal-title":"J Neurointerv Surg"},{"key":"R50-20260424","doi-asserted-by":"crossref","first-page":"255\u201363","DOI":"10.1016\/j.bbi.2017.11.019","article-title":"Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia-reperfusion injury by strengthening the blood-brain barrier function and anti-thrombo-inflammatory property","volume":"69","author":"Chen","year":"2018","journal-title":"Brain Behav Immun"},{"key":"R51-20260424","doi-asserted-by":"crossref","first-page":"95\u2013106","DOI":"10.1159\/000528922","article-title":"Advances in futile reperfusion following endovascular treatment in acute ischemic stroke due to large vessel occlusion","volume":"86","author":"Wang","year":"2023","journal-title":"Eur Neurol"},{"key":"R52-20260424","doi-asserted-by":"crossref","first-page":"1056\u201361","DOI":"10.1111\/ene.14170","article-title":"Low-dose rescue tirofiban in mechanical thrombectomy for acute cerebral large-artery occlusion","volume":"27","author":"Yang","year":"2020","journal-title":"Eur J Neurol"},{"key":"R53-20260424","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jvir.2018.08.021","article-title":"Safety of intra-arterial tirofiban administration in ischemic stroke patients after unsuccessful mechanical thrombectomy","volume":"30","author":"Zhang","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"R54-20260424","doi-asserted-by":"crossref","first-page":"1756\u201362","DOI":"10.3174\/ajnr.A4402","article-title":"Histologic analysis of retrieved clots in acute ischemic stroke: correlation with stroke etiology and gradient-echo MRI","volume":"36","author":"Kim","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"R55-20260424","doi-asserted-by":"crossref","first-page":"278\u201380","DOI":"10.1016\/j.thromres.2012.04.008","article-title":"Thrombus components in cardioembolic and atherothrombotic strokes","volume":"130","author":"Sato","year":"2012","journal-title":"Thromb Res"},{"key":"R56-20260424","doi-asserted-by":"crossref","first-page":"86\u201392","DOI":"10.1016\/j.neurad.2014.01.124","article-title":"Thrombus composition in acute ischemic stroke: a histopathological study of thrombus extracted by endovascular retrieval","volume":"42","author":"Simons","year":"2015","journal-title":"J Neuroradiol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000004601","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:48:25Z","timestamp":1786038505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/JS9.0000000000004601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":56,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000004601","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"2025-05-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-12","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}